Trending Now
Adverum Biotechnologies Inc. (NASDAQ:ADVM) Announces Q3 2020 Results With FDA removing...
Adverum Biotechnologies Inc. (NASDAQ:ADVM) has announced recent corporate updates and financial results for Q3 2020.
Adverum advancing DME and wet AMD programs
Laurent Fischer, the...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics
Investors and industry watchers are closely monitoring CytomX Therapeutics, Inc. (NASDAQ: CTMX), which has seen a significant uptick in its stock price...
MAKE IT MODERN
LATEST REVIEWS
PharmaCyte Biotech Inc. (NASDAQ: PMCB To Expand Product Pipeline to Malignant...
PharmaCyte Biotech Inc. (NASDAQ: PMCB) has announced that it will expand its product pipeline to include diabetes and malignant ascites programs.
PharmaCyte completed two offerings...
MAKE IT MODERN
PERFORMANCE TRAINING
Citius Pharmaceuticals (NASDAQ:CTXR) And Novellus Therapeutics Enter Exclusive Global Licensing Agreement For Proprietary iMSC...
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) has announced that it has entered an exclusive license agreement with Novellus Therapeutics limited to licensing iPSC-derived mesenchymal stem cells...
Affimed NV (NASDAQ:AFMD) And NKMax America Sign Collaborative Deal To Study A AFM24 and...
Affimed NV (NASDAQ:AFMD) recently announced that it signed a collaborative agreement with NKMax America Inc., through which they will both investigate a combination therapy...
The BITO ETF: What to Know and How to Play It (RIOT, ISWH, HIVE,...
The long-awaited day is finally here: Bitcoin has an ETF. And not just a foreign OTC-traded trust. A real ETF. A real...
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Enter Into a Securities Purchase Agreement for a $25 Million...
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) has acquired a $25 million private placement with affiliates of an existing shareholder, RTW Investments, LP. This was accomplished through...
Crypto Acceptance Continues to Steer the Bull (HVBTF, RIOT, CLKA, MARA)
The main factor driving the Bitcoin bull isn’t the debasement of fiat currencies that we have seen in response to the global...
MAKE IT MODERN
